Les Meilleurs doctors pour le traitement de chondrosarcome en Israël - TOP-8 des médecins

Leader dans le traitement des sarcomes avec plus de 25 ans à la tête de l'unité d'oncologie des tissus mous et des os au centre médical Sourasky.

• Formation spécialisée (Fellowship) à l'Institut Gustave Roussy à Paris, un centre de renommée mondiale pour les sarcomes
• Membre de la faculté du groupe Sarcome de l'European Society of Medical Oncology (ESMO)
• Auteur de nombreuses publications sur l'oncologie orthopédique et les protocoles de traitement

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Directeur de l'hématologie-oncologie pédiatrique au centre médical Sourasky – spécialisé dans le traitement du cancer des os chez l'enfant.

• Expert dans le traitement du sarcome chez l'enfant
• Formé à l'Institut orthopédique Rizzoli – un centre de renommée mondiale
• Coordonner le traitement du cancer des os avec les équipes d'oncologie-orthopédie
• Membre de l'ISPHO – l'association israélienne d'hémato-oncologie pédiatrique

Dirige un département dédié aux lésions osseuses métastatiques au centre médical Ichilov – l'un des plus grands hôpitaux d'Israël.

• Se spécialiser exclusivement en orthopédie oncologique, traitant les cancers des os.
• Effectuer des stages cliniques avancés en Israël et aux États-Unis.
• Occuper un poste universitaire de haut niveau en tant que professeur à l'université de Tel Aviv.
• Se former à la prestigieuse Université hébraïque de Jérusalem.

Le Dr Amir est un spécialiste de la chirurgie conservatrice des membres pour les cancers des os et des tissus mous au centre médical Sourasky d'Israël (Ichilov).

• Formation spécialisée (Fellowship) en oncologie orthopédique au National Cancer Institute des États-Unis et à l'Université de Toronto
• Membre actif de l'American Musculoskeletal Tumor Society (MSTS) et de l'International Society of Limb Salvage (ISOLS)
• Lauréat de plusieurs prix, dont la bourse Tannenbaum pour l'excellence en oncologie chirurgicale
• Se concentre sur les sarcomes, avec une expertise dans les cas complexes nécessitant des techniques de reconstruction

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.